Glenmark India
A new way for a new world
Empowering Patients
with Hope
About Us
Committed to Enriching Patient Lives
At Glenmark Pharmaceuticals Limited, we are dedicated to improving patient outcomes through our extensive portfolio of innovative healthcare solutions. As a leading, research-led global pharmaceutical company, we operate across branded, generics, and OTC segments. Our state-of-the-art manufacturing facilities and R&D centers enable us to focus on addressing unmet patient needs in key therapy areas, including Respiratory, Dermatology, Oncology, Diabetes, and Cardiovascular health.
In our quest to develop groundbreaking therapies, Glenmark is pioneering two complementary paths: discovering novel chemical and biological entities and creating specialty products like RYALTRIS® that bridge gaps in treatment. Through our collaboration with Ichnos Sciences, our fully owned US subsidiary, we have formed the Ichnos Glenmark Innovation alliance. This partnership harnesses diverse modalities, cutting-edge technologies, and shared expertise to advance cancer treatment, supported by a robust pipeline of innovative molecules currently in clinical development across oncology and immunology.
At Glenmark, our commitment to patient-centric innovation drives us to deliver high-quality, accessible healthcare solutions that make a meaningful difference in the lives of patients around the world.
Our Vision
To Emerge as a Leading, Research-Led, Global Pharmaceutical Company
Our Values
ACHIEVEMENT
We value the achievement of objectives and consistently strive towards our vision, with perseverance.
We value the achievement of objectives and consistently strive towards our vision, with perseverance.
RESPECT
We respect all our stakeholders.
KNOWLEDGE
We place an importance on knowledge such that it empowers our people to find innovative solutions to manage change.
Leadership
Alok Malik
President and Business Head – India Formulations
Driving Innovation and Access
India is a strategic stronghold for Glenmark. We are steadfast in our mission to enhance patient lives through affordable, accessible healthcare solutions that meet the highest global standards. With a strong focus on patient-centric care, we have launched several initiatives and programs that support patients throughout the treatment journey. Ongoing clinical trials are building a robust pipeline with complex generics and specialty medicines, delivering efficacy and aligning with the evolving healthcare landscape. We are committed to leading the transformation of healthcare in India, ensuring every patient has access to the best possible care.
Ranked 13*
Ranked 13*
in the Indian pharmaceuticals industry.
2nd* fastest growing companies
2nd* fastest growing companies
amongst the top 15 players in the Indian Pharmaceuticals Industry.
2nd Indian Pharmaceutical company
2nd Indian Pharmaceutical company
to receive Science based Target initiative’s (SBTi) seal of approval certification after a rigorous 5-stage review for our Green House Gas emission reduction target.
Over 3 Million Lives Touched
Over 3 Million Lives Touched
through CSR interventions
*According to IQVIA MAT Feb’25
Uniform Code of Pharmaceuticals Marketing Practices
At Glenmark, our Uniform Code ensures all marketing is ethical, transparent, and regulatory compliant, providing accurate information to healthcare professionals and patients.